Michael Sardano - 11 Jan 2024 Form 4 Insider Report for Sensus Healthcare, Inc. (SRTS)

Reporting relationship: PRESIDENT AND GENERAL COUNSEL
Issuer ticker: SRTS
Reported as of: 11 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jan 2024, 13:35:52 UTC
Prior SEC filing: 28 Aug 2023
Next SEC filing: 23 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Michael Sardano

Key filing fact

Michael Sardano filed Form 4 for Sensus Healthcare, Inc. (SRTS) on 16 Jan 2024.

Key facts

This page summarizes Michael Sardano's Form 4 filing for Sensus Healthcare, Inc. (SRTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jan 2024, 13:35.

Change

Previous filing in this sequence was filed on 28 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTS transaction

Common Stock

Award

Transaction value: $0
Shares: +20,000
Change %: +34%
Price: $0.000000
Shares after: 78,774
Date: 11 Jan 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents 20,000 shares of stock granted to the reporting person by a committee of non-employee directors in compliance with Rule 16b-3 and pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan. 10,000 of these shares vested immediately. The remaining 10,000 shares will vest on January 11, 2025.